December 2011

A $707 million investment in cell-based influenza vaccine

The United States has provided a large sum of money to pharmaceutical giant Novartis to produce influenza vaccines grown in cell culture. According to CIDRAP: Novartis’s US efforts have been spurred by two major federal contracts. In 2006 the firm won a $220 million HHS contract to develop cell-based flu vaccines, and in January 2009 …

A $707 million investment in cell-based influenza vaccine Read More »

TWiV 161: Concerto in B

Hosts: Vincent Racaniello, Rich Condit, Alan Dove, and Gabriel Victora Vincent, Rich, Alan and Gabriel review the production of antibodies by B cells, and how high affinity antibodies are selected in the germinal centers of lymph nodes. Please help us by taking our listener survey. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV161.mp3″] Click the arrow above to play, or right-click to download …

TWiV 161: Concerto in B Read More »

TWiV 160: Moore tumor viruses

Hosts: Vincent Racaniello, Rich Condit, Alan Dove, Dickson Despommier, and Patrick Moore The TWiV team speaks with Patrick Moore about his discovery, with Yuan Chang, of two human tumor viruses, Kaposi’s sarcoma herpesvirus and Merkel cell polyomavirus. Please help us by taking our listener survey. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV160.mp3″] Click the arrow above to play, or right-click to download …

TWiV 160: Moore tumor viruses Read More »

Scroll to Top